EGFR inhibitor lapatinib treatment on a GBM patient induces the cleavage and nuclear translocation of a master transcriptional regulator of fatty acid synthesis, sterol regulatory element-binding protein 1 (SREBP-1) [49]. Here, EGFR is linked to glioblastoma.